Pre-Clinical CRO for Mucosal Injury (Mucositis), Cancer and Inflammation Studies
- Company Details
- Products & Services
- White Papers
- Press Releases
- Regional Offices
- Contact Company
Avaxia Biologics to Collaborate with Biomodels on Antibody Therapeutic for Inflammatory Bowel Disease
Avaxia Biologics, a biotechnology company developing oral antibodies for diseases of the GI tract, has announced that it has been awarded a Phase I Small Business Innovation Research grant...
Biomodels' Oral Mucositis Expertise Speeds Up FDA Approval for ActoGeniX's Phase 1b Trial of AGO13 in Cancer Patients
Pre-clinical research organisation Biomodels has announced that it has successfully collaborated with ActoGeniX, a development stage biopharmaceutical company, in obtaining FDA approval for...
Biomodels Scientists Develop Novel Model for Cancer Treatment-Related Fatigue
Scientists at Biomodels have successfully developed the first model that accurately duplicates human cancer treatment-related fatigue (CTRF). The new model shows that, as in human cancer...
Lubris and Biomodels Report Potential New Therapy for Osteoarthritis
Medical researchers have reported findings demonstrating that injecting the protein lubricin into knee joints can dramatically reduce cartilage degeneration. The discovery by scientists...